Cargando…
Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
Background: Behçet’s disease (BD) is associated with an increased risk of cancer. Few reports have been published on the relationship between drug exposure and the risk of cancer in patients with BD. Herein, we explored the relationship between pharmacologic interventions for BD and the risk of canc...
Autores principales: | Huang, Mao-Xin, Wang, Cai-Yun, Guo, Jin-Yan, Li, Jian-Hao, Li, Xiao-Hong, Zhang, Jiang-An, Yu, Jian-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329246/ https://www.ncbi.nlm.nih.gov/pubmed/34354582 http://dx.doi.org/10.3389/fphar.2021.661150 |
Ejemplares similares
-
Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
por: Wang, Yan-Ni, et al.
Publicado: (2022) -
The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021) -
Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011) -
Consistency of recommendations for pharmacotherapy of rheumatoid arthritis
por: Hu, Yue, et al.
Publicado: (2022) -
Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)